(Press-News.org) Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective treatment options for the disease. In a new study, researchers at University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal adenocarcinomas (PDAC), the most common form of pancreatic cancer. The study will be published on January 2, 2025 in Cancer Research, a journal of the American Association for Cancer Research.
Normally, MICAL2 plays an important role in cell migration and morphology. But when the researchers measured gene expression in PDAC tumor cells, they found that an excessive amount of the enzyme was being produced compared with non-diseased cells — the first time MICAL2 has been experimentally linked to pancreatic cancer.
They also found that:
Among patients undergoing surgery to remove their PDAC tumors, those with low MICAL2 expression in their tumor cells survived about twice as long as those whose tumor cells produced more of the enzyme, suggesting that MICAL2 may be involved in progressing the disease to an advanced stage.
MICAL2 appears to supercharge the KRAS signaling pathway, which regulates cell growth, proliferation, and death and is known to be the primary driver of pancreatic tumor growth and the spread of the cancer to other tissues in the body. Silencing the MICAL2 gene in PDAC cells dramatically slowed the activity of the KRAS signaling pathway.
When tumor cells are deficient in MICAL2, the KRAS signaling pathway is unable to harvest nutrients that lead to tumor growth.
MICAL2 expression promotes tumor cell division, migration and the invasion of healthy tissue.
The findings suggest that MICAL2 could be a promising target for PDAC drug therapies, according to senior author Andrew Lowy, M.D., professor and division chief of surgical oncology at UC San Diego School of Medicine and associate clinical director for surgery at UC San Diego Moores Cancer Center.
“Pancreatic cancer has the highest mortality rate of any common cancer and thus current treatments are woefully inadequate,” said Lowy. “We believe it will be possible to target MICAL2 with drugs as it is an enzyme in a class of proteins against which inhibiting drugs have been successfully made to treat other human diseases. We are now working to identify candidate drugs to begin the journey toward blocking MICAL2 function in pancreatic cancer.”
# # #
END
Research alert: Enzyme promoting tumor growth and spread in pancreatic cancer identified
2025-01-02
ELSE PRESS RELEASES FROM THIS DATE:
NIH officials assess threat of H5N1
2025-01-02
WHAT:
Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States believe that available treatments and vaccines, as well as those in development, are sufficient to prevent severe disease. However, the National Institutes of Health (NIH) and its federal partners remain focused on monitoring the virus and evaluating changes, according to leading officials at the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.
In a commentary published in the New England Journal of Medicine, NIAID Director Jeanne M. Marrazzo, M.D., M.P.H., and Michael G. Ison, M.D., M.S., chief ...
Study finds physical activity reduces chronic disease risk
2025-01-02
University of Iowa researchers are recommending all patients be surveyed about their physical activity levels, after a new study underscores the link between physical activity and chronic disease.
The study, led by Lucas Carr, associate professor in the Department of Health and Human Physiology, examined responses from more than 7,000 patients at University of Iowa Health Care Medical Center who noted their level of physical activity in a questionnaire.
From patients’ answers to the questionnaire, the researchers found that those who reported the highest level of physical activity — meaning they exercised moderately ...
Based on AI-powered De novo Generation, Insilico Medicine nominates ISM1745 as preclinical candidate targeting PRMT5
2025-01-02
Since 2021, Insilico Medicine has successfully nominated 22 preclinical candidates (PCCs) with the help of its proprietary Pharma.AI platform, among which 5 were nominated just the year of 2024.
The novel scaffold of ISM1745 is based on de novo generation results of Insilico’s Chemistry42, the generative AI platform combining more than 40 generative models.
With in vivo anti-tumor activity validated in multiple cancer models, the candidate compound showed robust in vivo efficacy as monotherapy as well as combination potential with chemotherapies, targeted agents including MAT2A inhibitor, and immunotherapies.
CAMBRIDGE, ...
A “ticking time bomb” for liver cancer
2025-01-02
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently diagnosed cancer and fourth leading cause of cancer deaths worldwide. The study, published in Nature, reveals a complex interplay between cellular metabolism and DNA damage that drives the progression of fatty liver disease to cancer. The findings suggest new paths forward for preventing and treating liver cancer and have significant implications on our understanding of cancer’s origin and the effects of diet on our DNA.
The incidence of the most common form of liver cancer, hepatocellular carcinoma (HCC), has grown by 25-30% in the past ...
Targeting tristetraprolin in basophils: A breakthrough in allergic inflammation treatment
2025-01-02
Inflammation is a crucial part of the body’s defense mechanism, playing a key role in fighting infections and repairing tissue damage. Basophils, a type of immune cell that makes up less than 1% of white blood cells, have recently emerged as critical players in triggering allergic responses by releasing pro-inflammatory cytokines like IL-4. Despite the established role of basophils in inflammation, the molecular mechanisms controlling their cytokine production have remained unclear.
To address this gap, a group of researchers from Institute of Science Tokyo, led by Professor Kensuke Miyake, conducted a study to explore the role of tristetraprolin ...
Bringing the magic of playing music to the virtual world
2025-01-02
Researchers are aiming to bring the magic of playing music in person to the virtual world.
The Joint Active Music Sessions (JAMS) platform, created at the University of Birmingham, uses avatars created by individual musicians and shared with fellow musicians to create virtual concerts, practice sessions, or enhance music teaching.
Dr Massimiliano (Max) Di Luca from the University of Birmingham explains: “A musician records themselves and sends the video to another musician. The software creates a responsive avatar ...
Psychedelic drug therapy may address mental health concerns in people with cancer and addiction
2025-01-02
One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new report suggests. A second new study found that treatment with psilocybin resulted in lasting, positive personality changes in patients with alcohol use disorder.
The first report’s findings were published online Oct. 7 in the journal Nature Mental Health, and the second published online Jan. 1 in a special edition of The American Journal of Psychiatry focused on psilocybin research.
In the first study, a team of experts at NYU Langone Health found that psilocybin accompanied by psychotherapy significantly reduced anxiety, ...
Too many men or too few women?—new study finds how the gender gap is framed affects perceptions of it
2025-01-02
To many, Vice President Kamala Harris’s loss in the 2024 presidential election was a sobering reminder of a larger and continuous gender gap across leadership positions in not only government, but also in business, higher education, and the military. A majority of Americans recognize the inadequacy of female representation in leadership, and the news media often portray women’s underrepresentation in these roles—but it nonetheless persists.
Recognizing that news coverage may have influence in forming attitudes and in driving ...
AI can improve ovarian cancer diagnoses
2025-01-02
A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is published in Nature Medicine.
“Ovarian tumours are common and are often detected by chance,” says Professor Elisabeth Epstein at the Department of Clinical Science and Education, Södersjukhuset (Stockholm South General Hospital), at Karolinska Institutet and senior consultant at the hospital’s Department of Obstetrics and Gynecology. “There is a serious shortage of ultrasound experts in many parts of the world, which has ...
Zebrafish protein unlocks dormant genes for heart repair
2025-01-02
Researchers from the Bakkers group at the Hubrecht Institute have successfully repaired damaged mouse hearts using a protein from zebrafish. They discovered that the protein Hmga1 plays a key role in heart regeneration in zebrafish. In mice, this protein was able to restore the heart by activating dormant repair genes without causing side effects, such as heart enlargement. This study, supported by the Dutch Heart Foundation and Hartekind Foundation, marks an important step toward regenerative therapies to prevent heart failure. The findings were published in Nature Cardiovascular Research on January 2, 2025.
After a heart attack, the human heart loses millions of muscle cells that cannot ...